US EditionPublished • loading... • Updated
Openai Launches Gpt-Rosalind, Its First Life Sciences-Specific Ai Model: Designed to Accelerate Drug Discovery with Amgen, Moderna and Thermo Fisher as Partners
Summary by WWWhat's New
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
OpenAI has introduced GPT-Rosalind, its first AI model specifically designed for a scientific domain: life sciences, biochemistry, genomics and protein engineering. Named after Rosalind Franklin (the crystallographer whose work was instrumental in discovering the DNA structure), the model is available as a research preview in ChatGPT, Codex and the OpenAI API, but access is restricted to a reliable access program for business customers verified …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
